Skip to main content
ATOMO DIAGNOSTICS LIMITED logo

ATOMO DIAGNOSTICS LIMITED — Investor Relations & Filings

Ticker · AT1 ISIN · AU0000080327 ASX Manufacturing
Open in API
Filings indexed 393 across all filing types
Latest filing 2025-02-27 Interim / Quarterly Rep…
Country AU Australia
Listing ASX AT1

About ATOMO DIAGNOSTICS LIMITED

https://www.atomodiagnostics.com/

Atomo Diagnostics Limited specializes in the design and manufacture of integrated rapid diagnostic test (RDT) platforms. The company focuses on improving the usability and reliability of point-of-care testing through its proprietary AtomoRapid technology. This platform integrates essential components, such as a safety lancet and a calibrated blood collection system, into a single, user-friendly device. Key applications include HIV screening, COVID-19 detection, and pregnancy testing. By simplifying the testing procedure and reducing the risk of user error, the company provides solutions for both professional clinical environments and consumer self-testing markets. Its products are designed to deliver laboratory-grade accuracy in decentralized settings, supporting global health initiatives and individual health management.

Recent filings

Filing Released Lang Actions
Appendix 4D and Half Year Report ended 31 Dec 2024 23 pages 1.1MB
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Atomo Diagnostics Limited Appendix 4D Half-year report' and references the half-year ended 31 December 2024. It contains detailed financial results including revenues, losses, earnings per share, net tangible assets, and a comprehensive Directors' report with operational review, business risks, and outlook. It also mentions the auditor's review report attached as part of the Half Year Financial Report. The content includes substantive financial data and analysis for a period shorter than a full fiscal year, consistent with an Interim / Quarterly Report. The document is approximately 15,000 characters, indicating it is a full report rather than a brief announcement or certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR).
2025-02-27 English
H1 FY25 Results Presentation 21 pages 1.6MB
Interim / Quarterly Report Classification · 95% confidence The document is titled 'H1 FY2025 RESULTS PRESENTATION' and contains detailed financial data including profit & loss, balance sheet, cash flow, and operational highlights for the first half of fiscal year 2025. It includes comprehensive financial statements and analysis, such as revenue, expenses, gross margin, cash flow activities, and operational expenditure trends. The document is about 15,000 characters long, indicating it is a full report rather than a brief announcement. The content is consistent with a comprehensive interim or quarterly financial report rather than a simple earnings release or investor presentation. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2025-02-27 English
Investor Webinar Presentation 1 page 209.8KB
Report Publication Announcement Classification · 95% confidence The document is an ASX announcement dated 26 February 2025, stating that Atomo Diagnostics will release its H1 FY25 Results on 28 February 2025 and that a results briefing webinar will be held on 3 March 2025. The document does not contain any actual financial data or detailed financial statements; it is merely announcing the upcoming release of the half-year results and the related investor presentation event. The document length is short (1699 characters), and it fits the pattern of a report publication announcement rather than the report itself. Therefore, according to the MENU VS MEAL RULE, this document should be classified as a Report Publication Announcement (RPA).
2025-02-25 English
Quarterly Activities/Appendix 4C Cash Flow Report 11 pages 3.5MB
Interim / Quarterly Report Classification · 95% confidence The document is an ASX announcement dated January 30, 2025, titled 'Quarterly Activity Report Q2 FY25'. It contains detailed operational highlights, financial data including revenue, cash receipts, operating costs, and cash on hand for the quarter ended December 31, 2024. It also includes an Appendix 4C quarterly cash flow report, which is a regulatory requirement for Australian listed entities to report quarterly cash flows. The document is approximately 15,000 characters long and contains substantive financial data and analysis for a quarter, not just an announcement of a report. Therefore, it fits the definition of an Interim / Quarterly Report (IR).
2025-01-29 English
Atomo Investor Webinar Presentation 1 page 188.7KB
Investor Presentation Classification · 90% confidence The document is an ASX announcement dated 28 January 2025 about an upcoming investor webinar presentation related to the Q2 FY25 results release scheduled for 30 January 2025. It invites investors and analysts to a webinar hosted by the CEO and provides contact information. The document does not contain actual financial data or detailed financial statements but is an announcement of an event (webinar) to discuss upcoming quarterly results. The document length is short (1709 characters), and it serves as a notice rather than the report itself. Therefore, it fits best as an Investor Presentation (IP) announcement or a notice about an investor event. Given the options, the closest classification is Investor Presentation (IP) because it is about a presentation for investors focusing on financials and company updates, even though the actual presentation is to be held later.
2025-01-27 English
Atomo Secures Long Term Agreement with Newfoundland 2 pages 192.6KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated January 14, 2025, regarding a new long-term supply agreement between Atomo Diagnostics and Newfoundland Diagnostics. It details the terms of the agreement, including distribution rights and order quantities. The content focuses on a business partnership and commercial agreement rather than financial results, regulatory filings, or management changes. The document length is 3396 characters, which is relatively short and does not contain financial statements or detailed financial data. It is not an annual or interim report, earnings release, or any form of regulatory filing. It is a capital/financing update related to a supply agreement and business development. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2025-01-13 English

Browse filings by year

7 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.